15 results on '"Zabana, Y."'
Search Results
2. European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
3. P606 Phenotypic characteristics and use of therapeutic resources in elderly-onset inflammatory bowel disease: A multicentre, case-control study
4. P046 Lymphocytic and collagenous colitis: two clinically similar entities but with a distinct immunological pattern
5. DOP081 Long-term natural history of postoperative recurrence in patients on preventive treatment with azathioprine
6. P680 The Notch signaling pathway could be involved in the early post-surgical recurrence of Crohn's disease
7. P282 Cervical dysplasia and cancer in inflammatory bowel disease (IBD) women. Should we increase PAP test surveillance? A Spanish retrospective study
8. P106 - Prevalence of alterations of bone mineral density in new-onset inflammatory bowel disease and associated risk factors
9. P059 - Incidence of pre-malignant lesions in patients with long standing ulcerative colitis
10. P064 - Influence of smoking on the clinical outcome of new-onset Crohn's disease
11. P241 FERTILITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
12. P120 IMPACT OF THE AVAILABILITY OF IMMUNEMODULATORS OR INFLIXIMAB ON THE TREATMENT AND DISEASE COURSE IN TWO HOSPITAL COHORTS OF NEWLY-DIAGNOSED CROHN'S DISEASE (CD) PATIENTS
13. P093 INFLIXIMAB REINTRODUCTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE PREVIOUSLY TREATED WITH A 3-INFUSION INDUCTION REGIMEN IS NOT ASSOCIATED TO A HIGHER RATE OF IMMUNE-MEDIATED ADVERSE EFFECTS
14. P092 PROSPECTIVE STUDY OF EARLY PREDICTORS OF RESPONSE TO CORTICOSTEROIDS (CS) IN MODERATE-TO-SEVERE ACUTE FLARES OF ULCERATIVE COLITIS (UC) AND VALIDATION IN AN INDEPENDENT COHORT
15. P062 TUBERCULOUS CHEMOPROPHYLAXIS REQUIREMENTS AND SAFETY IN INFLAMMATORY BOWEL DISEASE PATIENTS PRIOR TO ANTI-TNF THERAPY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.